Clinical Trial Update: Avelumab In Patients With Previously Treated Advanced Stage Classical Hodgkin's Lymphoma (JAVELIN HODGKINS) [Phase 1]

View source ↗

Summary

Phase 1 trial update for avelumab in previously treated advanced classical Hodgkin's lymphoma (JAVELIN HODGKINS) has terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Avelumab (avelumab)

Snippet

Sponsor: Pfizer | Conditions: Hodgkins Lymphoma | Phase 1 | Status: TERMINATED | Results posted: 2020-03-18